SG Americas Securities’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$604M Buy
4,780,493
+3,812,458
+394% +$502M 0.34% 45
2026
Q1
$135M Sell
968,035
-300,832
-24% -$42.1M 0.15% 115
2025
Q4
$156M Buy
1,268,867
+665,369
+110% +$80.9M 0.2% 74
2025
Q3
$67M Buy
603,498
+559,883
+1,284% +$63.6M 0.23% 58
2025
Q2
$4.84M Sell
43,615
-60,096
-58% -$6.4M 0.02% 475
2025
Q1
$11.6M Buy
103,711
+68,993
+199% +$7.12M 0.04% 284
2024
Q4
$3.21M Sell
34,718
-52,541
-60% -$4.73M 0.01% 449
2024
Q3
$7.32M Sell
87,259
-728,788
-89% -$55.6M 0.03% 328
2024
Q2
$56M Buy
816,047
+661,055
+427% +$44.1M 0.33% 54
2024
Q1
$11.4M Buy
154,992
+52,494
+51% +$4.04M 0.05% 330
2023
Q4
$8.3M Buy
102,498
+33,108
+48% +$2.58M 0.08% 241
2023
Q3
$5.2M Sell
69,390
-50,865
-42% -$3.91M 0.06% 279
2023
Q2
$9.27M Buy
120,255
+56,255
+88% +$4.49M 0.07% 186
2023
Q1
$5.31M Sell
64,000
-160,650
-72% -$13.3M 0.06% 251
2022
Q4
$19.3M Buy
224,650
+148,448
+195% +$11.8M 0.24% 80
2022
Q3
$4.7M Sell
76,202
-23,045
-23% -$1.45M 0.06% 274
2022
Q2
$6.13M Sell
99,247
-25,505
-20% -$1.58M 0.07% 255
2022
Q1
$7.42M Buy
124,752
+20,128
+19% +$1.29M 0.05% 286
2021
Q4
$7.6M Buy
104,624
+41,155
+65% +$2.83M 0.04% 343
2021
Q3
$4.43M Sell
63,469
-125,041
-66% -$8.78M 0.02% 621
2021
Q2
$13M Sell
188,510
-560,713
-75% -$37.4M 0.06% 272
2021
Q1
$48.4M Buy
749,223
+245,868
+49% +$15.9M 0.25% 67
2020
Q4
$29.3M Buy
503,355
+312,965
+164% +$18.9M 0.16% 102
2020
Q3
$12M Buy
190,390
+71,049
+60% +$4.93M 0.08% 164
2020
Q2
$9.18M Sell
119,341
-36,317
-23% -$2.78M 0.08% 190
2020
Q1
$11.6M Sell
155,658
-60,451
-28% -$4.18M 0.11% 160
2019
Q4
$14M Sell
216,109
-163,561
-43% -$10.7M 0.13% 128
2019
Q3
$24.1M Sell
379,670
-137,916
-27% -$9.02M 0.2% 85
2019
Q2
$35M Buy
517,586
+486,125
+1,545% +$32M 0.24% 72
2019
Q1
$2.04M Sell
31,461
-443,855
-93% -$29.5M 0.02% 827
2018
Q4
$29.7M Sell
475,316
-692,233
-59% -$48.4M 0.26% 74
2018
Q3
$90.1M Buy
1,167,549
+563,523
+93% +$42.6M 0.67% 17
2018
Q2
$42.8M Buy
604,026
+295,811
+96% +$20.9M 0.39% 43
2018
Q1
$23.2M Buy
308,215
+167,359
+119% +$13.3M 0.19% 97
2017
Q4
$10.1M Buy
140,856
+92,283
+190% +$7.01M 0.09% 179
2017
Q3
$3.94M Sell
48,573
-383,932
-89% -$29.4M 0.03% 437
2017
Q2
$30.6M Sell
432,505
-794,103
-65% -$52.8M 0.28% 69
2017
Q1
$83.3M Sell
1,226,608
-707,962
-37% -$49.8M 0.74% 16
2016
Q4
$139M Buy
1,934,570
+1,581,648
+448% +$118M 1.16% 5
2016
Q3
$27.9M Buy
352,922
+231,032
+190% +$18.8M 0.29% 54
2016
Q2
$10.2M Sell
121,890
-325,148
-73% -$28.9M 0.07% 201
2016
Q1
$41.1M Sell
447,038
-3,245,409
-88% -$293M 0.3% 45
2015
Q4
$374M Sell
3,692,447
-245,432
-6% -$25.5M 2.65% 5
2015
Q3
$131M Buy
3,937,879
+3,115,228
+379% +$346M 0.79% 19
2015
Q2
$96.3M Buy
822,651
+84,700
+11% +$9.26M 0.63% 25
2015
Q1
$72.4M Sell
737,951
-326,127
-31% -$33.1M 0.43% 36
2014
Q4
$100M Sell
1,064,078
-431,429
-29% -$44.6M 0.49% 43
2014
Q3
$159M Buy
1,495,507
+2,594
+0.2% +$254K 0.94% 12
2014
Q2
$124M Sell
1,492,913
-158,793
-10% -$12.4M 0.72% 20
2014
Q1
$117M Buy
1,651,706
+141,207
+9% +$11.1M 0.51% 33
2013
Q4
$114M Sell
1,510,499
-204,761
-12% -$14.3M 0.47% 38
2013
Q3
$108M Buy
1,715,260
+130,810
+8% +$7.82M 0.44% 45
2013
Q2
$81.1M Buy
+1,584,450
New +$82.6M 0.4% 54

Other funds holding GILD

SG Americas Securities's GILD Position: Q2 2026 in Review

SG Americas Securities increased its Gilead Sciences (GILD) stake by 394% in Q2 2026, buying an estimated $502M and bringing the position to 4,780,493 shares worth $604M. The position accounts for 0.34% of the portfolio, ranked #45.

SG Americas Securities first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • SG Americas Securities held 4,780,493 shares of Gilead Sciences worth $604M as of Q2 2026.
  • SG Americas Securities bought 3,812,458 Gilead Sciences shares in Q2 2026, an estimated $502M.
  • Gilead Sciences made up 0.34% of SG Americas Securities's portfolio in Q2 2026, its #45 holding.
  • SG Americas Securities first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.